J2 Capital Management Inc

Position in GILD — Gilead Sciences, Inc.

CIK 1586882 TROY, MI

Position in GILD

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$462,404

-$64,414 QoQ

Shares Held

3,660

-3.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.03%

of 13F equity value

Holder Rank

#1,407

of 2,266 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

J2 Capital Management Inc holds $5,355,034 across 6 Drug Manufacturers - General names. GILD ranks #6 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	7,224	$1,817,847
2	LLY	ELI LILLY & Co	824	$988,330
3	MRK	Merck & Co., Inc.	6,147	$789,889
4	JNJ	Johnson & Johnson	2,765	$702,227
5	GSK	GSK plc	11,338	$594,337
6	GILD	Gilead Sciences, Inc. This page	3,660	$462,404

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$462,404	3,660	-3.2%	Shares	Sole	2026-07-20
2026-03-31	$526,818	3,780	+2.8%	Shares	Sole	2026-04-21
2025-12-31	$451,314	3,677	-2.6%	Shares	Sole	2026-01-20
2025-09-30	$418,914	3,774	-2.3%	Shares	Sole	2025-10-14
2025-06-30	$428,401	3,864	+58.9%	Shares	Sole	2025-07-21
2025-03-31	$272,505	2,432	—	Shares	Sole	2025-04-08
No filing history on record for this holder in this stock.